Data layers Raw facts Calculated Model prediction AI interpretation

IPO Timeline Raw facts

Broker Deadline
Morning deadline
HKEX Deadline
Noon deadline
Broker Results (T-2)
Some brokers release in afternoon
Grey Market (T-1)
Afternoon
HKEX Allotment (T-1)
Evening
Registrar Allotment (T-1)
Evening
Listing Day (T)
First day of trading

Company Overview

Stock NameJiangxi Bio
Stock Code06915
Company Full NameJiangxi Institute of Biological Products Inc.
IndustryHealthcare
Principal ActivitiesWe are the largest provider and exporter of human tetanus antitoxin (human TAT) in China, a vertically integrated antiserum platform company spanning the entire industry chain, primarily engaged in the research and development, production and sales of human and veterinary antiserum products and veterinary anti-infective drugs.
Listing Date2026-06-30
Listing Rules EraNew Rules (after Aug 2025)
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國 江西省吉安市 井岡山經濟技術開發區 火炬大道198號
Business Address (Hong Kong)香港 銅鑼灣 勿地臣街1號 時代廣場二座31樓
Place of IncorporationChina
Listing MethodGlobal Offering
Listing BoardMain Board
Websitewww.jxswzp.cn
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact卓佳证券登记有限公司,香港金钟道89号力宝中心1座31楼3101-3103室
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism B
Offer PriceHK$ 11.20 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 5,600
Par ValueRMB 1.0 / shares
Offer Period2026-06-22 to 2026-06-25
Global Offering Shares36,234,500 shares
HK Public Offer Shares (Initial)3,623,500 shares (10.0%)
Public Offer Lots (Initial)7,247lots (Pool A3,623lots,Pool B3,624lots)
International Placing Shares (Initial)32,611,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO308,377,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)China International Capital Corporation Hong Kong Securities Limited CE AEN894
Cornerstone Share12.3%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 405,826,400

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 5,600
2 lots 1,000 HK$ 11,200
3 lots 1,500 HK$ 16,800
4 lots 2,000 HK$ 22,400
5 lots 2,500 HK$ 28,000
6 lots 3,000 HK$ 33,600
7 lots 3,500 HK$ 39,200
8 lots 4,000 HK$ 44,800
9 lots 4,500 HK$ 50,400
10 lots 5,000 HK$ 56,000
12 lots 6,000 HK$ 67,200
14 lots 7,000 HK$ 78,400
16 lots 8,000 HK$ 89,600
18 lots 9,000 HK$ 100,800
20 lots 10,000 HK$ 112,000
30 lots 15,000 HK$ 168,000
40 lots 20,000 HK$ 224,000
50 lots 25,000 HK$ 280,000
60 lots 30,000 HK$ 336,000
70 lots 35,000 HK$ 392,000
80 lots 40,000 HK$ 448,000
90 lots 45,000 HK$ 504,000
100 lots 50,000 HK$ 560,000
120 lots 60,000 HK$ 672,000
140 lots 70,000 HK$ 784,000
160 lots 80,000 HK$ 896,000
180 lots 90,000 HK$ 1,008,000
200 lots 100,000 HK$ 1,120,000
400 lots 200,000 HK$ 2,240,000
600 lots 300,000 HK$ 3,360,000
800 lots 400,000 HK$ 4,480,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,000 lots 500,000 HK$ 5,600,000
1,200 lots 600,000 HK$ 6,720,000
1,400 lots 700,000 HK$ 7,840,000
1,600 lots 800,000 HK$ 8,960,000
1,800 lots 900,000 HK$ 10,080,000
2,000 lots 1,000,000 HK$ 11,200,000
2,400 lots 1,200,000 HK$ 13,440,000
2,800 lots 1,400,000 HK$ 15,680,000
3,200 lots 1,600,000 HK$ 17,920,000
3,623 lots 1,811,500 HK$ 20,288,800

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
HK Market Cap HK$ 2.41B
Est. Threshold HK$ 9.44B
Analysis Result HK market cap below threshold, need +292%

Valuation & Financials

Market Cap (at Offer Price)HK$ 3,453,822,400
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusNet profit RMB 94.8 million
Period-End Cash BalanceRMB 73.83 million
Listing Expenses~HK$ 67,000,000
Listing Expenses / Funds Raised~16.5%
Total Pre-IPO Investmentapproximately RMB 90.7 million
First Day CloseLoading...

Underwriting Syndicate

Joint Sponsors (2)
China International Capital Corporation Hong Kong Securities Limited CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650
Sponsor cum Overall Coordinator (2)
China International Capital Corporation Hong Kong Securities Limited CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650
Overall Coordinators (3)
China International Capital Corporation Hong Kong Securities Limited CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 Futu Securities International (HONG KONG) Limited CE AZT137
Joint Global Coordinators (3)
China International Capital Corporation Hong Kong Securities Limited CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 Futu Securities International (HONG KONG) Limited CE AZT137
Joint Bookrunners (6)
China International Capital Corporation Hong Kong Securities Limited CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 Futu Securities International (HONG KONG) Limited CE AZT137 Guosen Securities (HK) Brokerage Company, Limited CE AUI491 CMBC SECURITIES COMPANY LIMITED CE APU820 Arta Asset Management Limited CE AQW828
Joint Lead Managers (6)
China International Capital Corporation Hong Kong Securities Limited CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 Futu Securities International (HONG KONG) Limited CE AZT137 Guosen Securities (HK) Brokerage Company, Limited CE AUI491 CMBC SECURITIES COMPANY LIMITED CE APU820 Arta Asset Management Limited CE AQW828
Capital Market Intermediaries (6)
China International Capital Corporation Hong Kong Securities Limited CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 Futu Securities International (HONG KONG) Limited CE AZT137 Guosen Securities (HK) Brokerage Company, Limited CE AUI491 CMBC SECURITIES COMPANY LIMITED CE APU820 Arta Asset Management Limited CE AQW828
Stabilizing Manager (1)
China International Capital Corporation Hong Kong Securities Limited CE AEN894

Service Providers

RoleInstitution
Legal Advisor to Company 美迈斯律师事务所
北京市康达律师事务所
Legal Advisor to Sponsors/Underwriters 海问律师事务所有限法律责任合伙
竞天公诚律师事务所
Auditor and Reporting Accountant 德勤‧关黄陈方会计师行
Industry Advisor 弗若斯特沙利文(北京)咨询有限公司上海分公司
Compliance Advisor Patrons Capital Limited CE BSM550
Receiving Banks 招商永隆银行有限公司
中国农业银行股份有限公司香港分行

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 WSH 50,000,000 HKD 4,464,000 12.32% 1.45% 6 months 2026-12-30

Directors & Management

PositionChinese nameEnglish Name
Chairman / Executive Director敬玥JING Yue
Company Secretary敬瑞華、馮羨婷—
Non-Executive Director于愛蓮YU Ailian
Independent Non-Executive Director鄒平學ZOU Pingxue
Executive Director姚曉東YAO Xiaodong
Non-Executive Director肖長清XIAO Changqing
Independent Non-Executive Director曾曉亮TSANG Hiu Leong
Executive Director李長青LI Changqing
Independent Non-Executive Director吳迪WU Di
Executive Director敬瑞華JING Ruihua

Major Shareholders

Major Shareholders & Holdings前海天正 (wholly owned by 海南至正) holds 66.05% equity interest
About this page

This page shows Jiangxi Bio (06915) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect